Sorafenib and neutropenia 
Sorafenib and neutropenia Patient Reports February 10, 2012
Sorafenib Side Effects Report #5410915-3
Sorafenib side effect was reported by a Health Professional from UNITED STATES on July 31, 2007. Male patient, 83 years of age, weighting 205.0 lb, was diagnosed with prostate cancer metastatic and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: dyspnoea, mucosal inflammation, neutropenia, oesophagitis. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with MITOXANTRONE, PREDNISONE, ZOLOFT, COUMADIN, SYNTHROID, LASIX, MAGIC MOUTHWASH. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5488098-3
Sorafenib side effect was reported by a Health Professional from UNITED STATES on Oct 10, 2007. Male patient, 83 years of age, weighting 205.0 lb, was diagnosed with prostate cancer metastatic and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: dyspnoea, mucosal inflammation, neutropenia, oesophagitis. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with MITOXANTRONE, PREDNISONE, ZOLOFT, COUMADIN, SYNTHROID, LASIX, MAGIC MOUTHWASH. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5502767-8
Sorafenib side effect was reported by a Health Professional from UNITED STATES on Oct 29, 2007. Male patient, 83 years of age, weighting 205.0 lb, was diagnosed with prostate cancer metastatic and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: dyspnoea, mucosal inflammation, neutropenia, oesophagitis. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with MITOXANTRONE, PREDNISONE, ZOLOFT, COUMADIN, SYNTHROID, LASIX, MAGIC MOUTHWASH. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5639650-3
Sorafenib side effect was reported by a Physician from UNITED STATES on Feb 14, 2008. Male patient, 76 years of age, was diagnosed with prostate cancer metastatic and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: chest pain
, deep vein thrombosis , muscular weakness, neutropenia, oesophagitis, pain in extremity, peripheral motor neuropathy. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with MITOXANTRONE, ZOMETA, ULTRAM, BUSPAR, KYTRIL, COMPAZINE, AVODART. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5887639-1
Sorafenib side effect was reported by a Physician from UNITED STATES on Sept 10, 2008. Male patient, 76 years of age, was diagnosed with prostate cancer metastatic and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: chest pain
, deep vein thrombosis , dysphagia, muscular weakness, neutropenia, oesophagitis, pain in extremity, peripheral motor neuropathy. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with MITOXANTRONE, ZOMETA, ULTRAM, BUSPAR, KYTRIL, COMPAZINE, AVODART. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #6136313-5
Sorafenib side effect was reported by a Physician from UNITED STATES on Mar 23, 2009. Male patient, 76 years of age, weighting 160.9 lb, was diagnosed with prostate cancer metastatic and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: chest pain
, deep vein thrombosis , dysphagia, muscular weakness, neutropenia, oesophagitis, pain in extremity, peripheral motor neuropathy. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with MITOXANTRONE, ZOMETA, ULTRAM, BUSPAR, KYTRIL, COMPAZINE. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5649447-6
Sorafenib side effect was reported by a Physician from BRAZIL on Sept 06, 2007. Female patient, 81 years of age, weighting 121.3 lb, was diagnosed with non-small cell lung cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: anaemia, anorexia, constipation
, dehydration, neutropenia, pain in extremity, subcutaneous nodule, thrombocytopenia, vomiting. Sorafenib dosage: unknown. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5393799-1
Sorafenib side effect was reported by a Physician from BELGIUM on July 18, 2007. Male patient, 71 years of age, weighting 152.1 lb, was diagnosed with non-small cell lung cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: cholangitis, neutropenia, pseudomonal sepsis. Sorafenib dosage: UNIT DOSE: 400 MG. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5402284-X
Sorafenib side effect was reported by a Physician from BELGIUM on July 30, 2007. Male patient, 71 years of age, weighting 152.1 lb, was diagnosed with non-small cell lung cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: cholangitis, neutropenia, pseudomonal sepsis. Sorafenib dosage: UNIT DOSE: 400 MG. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5535676-9
Sorafenib side effect was reported by a Physician from BELGIUM on Nov 30, 2007. Male patient, 71 years of age, weighting 152.1 lb, was diagnosed with non-small cell lung cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: cholangitis, neutropenia, pseudomonal sepsis. Sorafenib dosage: UNIT DOSE: 400 MG. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5594503-4
Sorafenib side effect was reported by a Physician from BELGIUM on Jan 11, 2008. Male patient, 71 years of age, weighting 152.1 lb, was diagnosed with non-small cell lung cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: cholangitis, neutropenia, pseudomonal sepsis. Sorafenib dosage: UNIT DOSE: 400 MG. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5811681-X
Sorafenib side effect was reported by a Consumer or non-health professional from MEXICO on July 03, 2008. Male patient, 70 years of age, weighting 180.8 lb, was diagnosed with non-small cell lung cancer, hypertension, diabetes mellitus, dyspnoea and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: cardiopulmonary failure, neutropenia, peptic ulcer
, respiratory distress, upper gastrointestinal haemorrhage. Sorafenib dosage: unknown. During the same period patient was treated with GEMCITABINE, CISPLATIN, LOSARTAN POTASSIUM, GLIBENCLAMIDE, METFORMIN, AMLODIPINE, PROPAFENONE, IPRATROPIUM BROMIDE. Patient was hospitalized. Patient died on 01/15/2008.Sorafenib Side Effects Report #5828412-X
Sorafenib side effect was reported by a Consumer or non-health professional from MEXICO on July 25, 2008. Male patient, 70 years of age, weighting 180.8 lb, was diagnosed with non-small cell lung cancer, hypertension, diabetes mellitus, dyspnoea and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: cardiopulmonary failure, neutropenia, peptic ulcer
, pneumonia , respiratory distress, upper gastrointestinal haemorrhage. Sorafenib dosage: unknown. During the same period patient was treated with GEMCITABINE, CISPLATIN, LOSARTAN POTASSIUM, GLIBENCLAMIDE, METFORMIN, AMLODIPINE, PROPAFENONE, IPRATROPIUM BROMIDE. Patient was hospitalized. Patient died on 01/15/2008.Sorafenib Side Effects Report #5887640-8
Sorafenib side effect was reported by a Consumer or non-health professional from MEXICO on Sept 09, 2008. Male patient, 70 years of age, weighting 180.8 lb, was diagnosed with non-small cell lung cancer, hypertension, diabetes mellitus and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, gastrointestinal toxicity, haematotoxicity, lung neoplasm malignant, mucosal inflammation, neutropenia, pneumonia
, respiratory distress. Sorafenib dosage: unknown. During the same period patient was treated with GEMCITABINE, CISPLATIN, LOSARTAN, GLYBURIDE, METFORMIN, AMLODIPINE. Patient was hospitalized. Patient died on 01/15/2008.Sorafenib Side Effects Report #6050404-9
Sorafenib side effect was reported by a Physician from ITALY on Jan 19, 2009. Male patient, 70 years of age, weighting 163.1 lb, was diagnosed with non-small cell lung cancer, prophylaxis, pain
, hypertriglyceridaemia, diabetes mellitus, arrhythmia and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: cardiac failure, dyspnoea, neutropenia, oedema. Sorafenib dosage: unknown. During the same period patient was treated with GEMCITABINE, LIMPIDEX, OXYCONTIN, ESKIM, AMARYL, ASPIRIN, SELOKEN. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #6069739-9
Sorafenib side effect was reported by a Physician from ITALY on Feb 03, 2009. Male patient, 70 years of age, weighting 163.1 lb, was diagnosed with non-small cell lung cancer, prophylaxis, pain
, hypertriglyceridaemia, diabetes mellitus, arrhythmia and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: cardiac failure, dyspnoea, neutropenia, pulmonary oedema. Sorafenib dosage: unknown. During the same period patient was treated with GEMCITABINE, LIMPIDEX, OXYCONTIN, ESKIM, AMARYL, ASPIRIN, SELOKEN. Patient was hospitalized. Patient died on 01/27/2009.Sorafenib Side Effects Report #5649426-9
Sorafenib side effect was reported by a Physician from ITALY on Feb 20, 2008. Male patient, 67 years of age, weighting 158.7 lb, was diagnosed with non-small cell lung cancer, ill-defined disorder, hypertension and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: hypercreatininaemia, neutropenia, thrombocytopenia. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, PLAVIX, ADALAT. Patient was hospitalized. Patient died on 03/23/2007.
Sorafenib Side Effects Report #5717671-X
Sorafenib side effect was reported by a Physician from ITALY on Apr 21, 2008. Male patient, 67 years of age, weighting 158.7 lb, was diagnosed with non-small cell lung cancer, ill-defined disorder, hypertension and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: hypercreatininaemia, neutropenia, thrombocytopenia. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, PLAVIX, ADALAT. Patient was hospitalized. Patient died on 03/23/2007.
Sorafenib Side Effects Report #5888505-8
Sorafenib side effect was reported by a Physician from ITALY on Apr 18, 2008. Male patient, 67 years of age, weighting 158.7 lb, was diagnosed with non-small cell lung cancer, ill-defined disorder, hypertension and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: hypercreatininaemia, neutropenia, thrombocytopenia. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, PLAVIX, ADALAT. Patient was hospitalized. Patient died on 03/23/2007.
Sorafenib Side Effects Report #6031078-X
Sorafenib side effect was reported by a Physician from SPAIN on Dec 23, 2008. Male patient, 65 years of age, was diagnosed with non-small cell lung cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: neutropenia, pneumonia
. Sorafenib dosage: unknown. During the same period patient was treated with CISPLATIN, GEMCITABINE. Patient died on 12/23/2008.Sorafenib Side Effects Report #5211852-X
Sorafenib side effect was reported by a Physician from UNITED KINGDOM on Jan 12, 2007. Male patient, 61 years of age, was diagnosed with non-small cell lung cancer, analgesic effect, blood pressure increased, antiemetic supportive care and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: abdominal rigidity, cardiac arrest
, constipation , deep vein thrombosis , dyspnoea, lung adenocarcinoma, neutropenia, pulmonary embolism . Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, PARACETAMOL, TRAMADOL, ATENOLOL, OMEPRAZOLE, ONDANSETRON. Patient was hospitalized. Patient died on 12/02/2006.Sorafenib Side Effects Report #5241395-9
Sorafenib side effect was reported by a Physician from UNITED KINGDOM on Feb 16, 2007. Male patient, 61 years of age, weighting 172.0 lb, was diagnosed with non-small cell lung cancer, analgesic effect, blood pressure increased, gastric ph decreased, antiemetic supportive care and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: abdominal rigidity, cardiac arrest
, constipation , deep vein thrombosis , dyspnoea, lung adenocarcinoma, neutropenia, pulmonary embolism . Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, PARACETAMOL, TRAMADOL, ATENOLOL, OMEPRAZOLE, ONDANSETRON. Patient was hospitalized. Patient died on 12/02/2006.Sorafenib Side Effects Report #5246571-7
Sorafenib side effect was reported by a Physician from UNITED KINGDOM on Feb 20, 2007. Male patient, 61 years of age, weighting 172.0 lb, was diagnosed with non-small cell lung cancer, analgesic effect, blood pressure increased, gastric ph decreased, antiemetic supportive care and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: abdominal rigidity, constipation
, deep vein thrombosis , dyspnoea, neutropenia, pulmonary embolism . Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, PARACETAMOL, TRAMADOL, ATENOLOL, OMEPRAZOLE, ONDANSETRON. Patient was hospitalized. Patient died on 12/02/2006.Sorafenib Side Effects Report #5262437-0
Sorafenib side effect was reported by a Physician from UNITED KINGDOM on Mar 06, 2007. Male patient, 61 years of age, weighting 172.0 lb, was diagnosed with non-small cell lung cancer, analgesic effect, blood pressure increased, gastric ph decreased, antiemetic supportive care and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: abdominal rigidity, constipation
, deep vein thrombosis , dyspnoea, neutropenia, pulmonary embolism . Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, ACETAMINOPHEN, TRAMADOL, ATENOLOL, OMEPRAZOLE, ONDANSETRON. Patient was hospitalized. Patient died on 12/02/2006.Sorafenib Side Effects Report #6017554-4
Sorafenib side effect was reported by a Physician from UNITED KINGDOM on Dec 19, 2008. Male patient, 61 years of age, weighting 172.0 lb, was diagnosed with non-small cell lung cancer, analgesia, blood pressure increased, gastric ph decreased, antiemetic supportive care and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: abdominal rigidity, constipation
, deep vein thrombosis , dyspnoea, neutropenia, pulmonary embolism . Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, ACETAMINOPHEN, TRAMADOL, ATENOLOL, OMEPRAZOLE, ONDANSETRON. Patient was hospitalized. Patient died on 12/02/2006.Sorafenib Side Effects Report #5306371-6
Sorafenib side effect was reported by a Physician from NETHERLANDS on Apr 13, 2007. Female patient, 54 years of age, weighting 119.0 lb, was diagnosed with non-small cell lung cancer, pain
, prophylaxis, constipation , sleep disorder and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: dyspnoea, malaise, neutropenia, weight decreased. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, MORPHINE, PANTOPRAZOLE, MALCOLON, TRYPTIZOL, TEMAZEPAM. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5737879-7
Sorafenib side effect was reported by a Physician from UNITED STATES on May 07, 2008. Male patient, 75 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: coagulopathy, metabolic acidosis, neutropenia. Sorafenib dosage: unknown. During the same period patient was treated with RHINTERLEUKIN, ACETAMINOPHEN, ALLOPURINOL, AMLODIPINE, FERROUS SULPHATE, FUROSEMIDE, GEMFIBROZIL, HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5114849-3
Sorafenib side effect was reported by a Physician from UNITED STATES on Feb 21, 2006. Male patient, 59 years of age, weighting 224.9 lb, was diagnosed with metastatic malignant melanoma, diabetes mellitus and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, hypotension, neutropenia. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with CARBOPLATIN, TAXOL, NOVOLOG, HUMULIN N, METFORMIN. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5158426-7
Sorafenib side effect was reported by a Physician from GERMANY on Nov 22, 2006. Male patient, 62 years of age, weighting 145.5 lb, was diagnosed with malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: neutropenia. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with PACLITAXEL, CARBOPLATIN. Patient recovered.
Sorafenib Side Effects Report #4973878-0
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 30, 2006. Male patient, 59 years of age, weighting 224.0 lb, was diagnosed with malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: body temperature increased, candidiasis, diarrhoea, haematocrit decreased, haemoglobin decreased, neutropenia, orthostatic hypotension, platelet count decreased, white blood cell count decreased. Sorafenib dosage: 400 MG BID ORAL. During the same period patient was treated with CARBOPLATIN, TAXOL, NOVOLOG, HUMULIN N, METFORMIN, GLYBURIDE, METHADONE, GABAPENTIN. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5004567-4
Sorafenib side effect was reported by a Health Professional from UNITED STATES on May 04, 2006. Male patient, 59 years of age, weighting 224.0 lb, was diagnosed with malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: candidiasis, dehydration, diarrhoea, haematocrit decreased, haemoglobin decreased, hypotension, neutropenia, platelet count decreased, pyrexia. Sorafenib dosage: unknown. During the same period patient was treated with CARBOPLATIN, TAXOL, NOVOLOG, HUMULIN N, METFORMIN, GLYBURIDE. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5150267-X
Sorafenib side effect was reported by a Physician from FRANCE on Mar 03, 2006. Male patient, 55 years of age, weighting 143.3 lb, was diagnosed with malignant melanoma, metastatic malignant melanoma, hypertension, pyrexia, unevaluable event and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: anaemia, anorexia, asthenia, disease progression, epistaxis, neutropenia, thrombocytopenia. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with DACARBAZINE, TEMERIT, EFFERALGAN, FLAMAZINE. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5027387-3
Sorafenib side effect was reported by a Pharmacist from UNITED STATES on Feb 23, 2006. Male patient, 53 years of age, was diagnosed with malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: neutropenia. Sorafenib dosage: 400 MG, BID, ORAL. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, NEULASTA. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #6077015-3
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 10, 2009. Male patient, 76 years of age, weighting 158.7 lb, was diagnosed with lung neoplasm malignant and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: blood creatinine increased, dehydration, dysphagia, neutropenia, peripheral ischaemia, platelet count decreased. Sorafenib dosage: TOTAL DAILY DOSE: 400 MG UNIT DOSE: 200 MG. During the same period patient was treated with CISPLATIN, ETOPOSIDE, LISINOPRIL, HYTRIN. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #6088352-0
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 16, 2009. Male patient, 76 years of age, weighting 158.7 lb, was diagnosed with lung neoplasm malignant and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: arterial thrombosis, blood creatinine increased, dehydration, dysphagia, gastrointestinal haemorrhage, neutropenia, peripheral ischaemia, platelet count decreased. Sorafenib dosage: TOTAL DAILY DOSE: 400 MG UNIT DOSE: 200 MG. During the same period patient was treated with CISPLATIN, ETOPOSIDE, LISINOPRIL, HYTRIN. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #6101149-8
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 24, 2009. Male patient, 76 years of age, weighting 158.7 lb, was diagnosed with lung neoplasm malignant, arterial thrombosis and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: arterial thrombosis, blood creatinine increased, dehydration, dysphagia, neutropenia, peripheral ischaemia, platelet count decreased, rectal haemorrhage. Sorafenib dosage: TOTAL DAILY DOSE: 400 MG UNIT DOSE: 200 MG. During the same period patient was treated with CISPLATIN, ETOPOSIDE, ARIXTRA, LISINOPRIL, HYTRIN. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5211700-8
Sorafenib side effect was reported by a Physician from CANADA on Jan 08, 2007. Male patient, 71 years of age, weighting 262.4 lb, was diagnosed with hypertension, dyspepsia and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: blood creatinine increased, hypotension, malaise, neutropenia, rash
. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with HYZAAR, ATENOLOL, ZANTAC. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5125927-7
Sorafenib side effect was reported by a Physician from CANADA on June 22, 2006. Male patient, 71 years of age, weighting 262.4 lb, was diagnosed with hypertension, dyspepsia and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: blood creatinine increased, hypotension, malaise, neutropenia, rash
, rash macular. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with HYZAAR, ATENOLOL, ZANTAC. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5450004-5
Sorafenib side effect was reported by a Physician from CANADA on Sept 10, 2007. Male patient, 71 years of age, weighting 262.4 lb, was diagnosed with hypertension, dyspepsia and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: blood creatinine increased, hypotension, malaise, neutropenia, rash
. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with HYZAAR, ATENOLOL, ZANTAC. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5049680-0
Sorafenib side effect was reported by a Consumer or non-health professional from CANADA on June 22, 2006. Male patient, 70 years of age, weighting 119.0 lb, was treated with Sorafenib. After drug was administered, patient experienced the following side effects: blood creatinine increased, hypotension, malaise, neutropenia, rash erythematous, rash macular. Sorafenib dosage: 400 MG, BID, ORAL. During the same period patient was treated with HYZAAR, ATENOLOL, ZANTAC. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5062837-8
Sorafenib side effect was reported by a Consumer or non-health professional from CANADA on July 17, 2006. Male patient, 70 years of age, weighting 262.4 lb, was treated with Sorafenib. After drug was administered, patient experienced the following side effects: blood creatinine increased, hypotension, malaise, neutropenia, rash erythematous. Sorafenib dosage: 400 MG, BID, ORAL. During the same period patient was treated with HYZAAR, ATENOLOL, ZANTAC. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5264640-2
Sorafenib side effect was reported by a Physician from ITALY on Feb 27, 2007. Female patient, 66 years of age, weighting 138.9 lb, was treated with Sorafenib. After drug was administered, patient experienced the following side effects: neutropenia, pyrexia, sepsis
. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with INTERFERON ALPHA. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5268169-7
Sorafenib side effect was reported by a Physician from ITALY on Mar 09, 2007. Female patient, 66 years of age, weighting 138.9 lb, was treated with Sorafenib. After drug was administered, patient experienced the following side effects: neutropenia, pyrexia, sepsis
. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with INTERFERON ALPHA. Patient was hospitalized. Patient recovered.